Clinical Trial Update: SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c [NA]

View source ↗

Summary

Clinical trial update for SWITCH study on insulin pump therapy to control HbA1c in adults with type 1 diabetes; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Medtronic MiniMed

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Diabetes Mellitus, Type 1 | NA | Status: COMPLETED | Results posted: 2019-09-16